Related references
Note: Only part of the references are listed.Performance of BRCA1/2 mutation prediction models in Asian Americans
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
BRCA1 regulates human mammary stem/progenitor cell fate
Suling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups
Esther M. John et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer
Constance D. Lehman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk
Kari Hemminki et al.
CANCER RESEARCH (2007)
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
William D. Foulkes et al.
BREAST CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50
Robert W. Haile et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen
G Arpino et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A comparison of bilateral breast cancers in BRCA carriers
JN Weitzel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer
SM Swain et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers
A Broeks et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The descriptive epidemiology of second primary breast cancer
JL Bernstein et al.
EPIDEMIOLOGY (2003)
Epidemiologic and molecular risk factors for contralateral breast cancer among young women
C Li et al.
BRITISH JOURNAL OF CANCER (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2:: Analysis of 10,000 individuals
TS Frank et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada
Y Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
LC Verhoog et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
